Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CVS

Key Considerations Before Investing in CVS Health (CVS)

Shares of Consumer Staples sector company CVS Health moved -0.0% today, and are now trading at a price of $79.84. The Large-Cap stock's daily volume was 284,422 compared to its average volume of 7,530,720. The S&P 500 index returned a 0.0% performance.

CVS Health Corporation provides health solutions in the United States. The company is based in Woonsocket and has 219,000 full time employees. Its market capitalization is $101,357,838,336. CVS Health currently offers its equity investors a dividend that yields 3.3% per year.

Over the last year, CVS's share price has increased by 33.4%, which represents a difference of 20.5% when compared to the S&P 500. The stock's 52 week high is $85.15 per share whereas its 52 week low is $43.56. CVS Health's average free cash flow over the last 5 years has been $11.62 Billion, but they have been decreasing at an average rate of -11.9%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 9,107,000 2,781,000 6,326,000 -39.14
2023 13,426,000 3,031,000 10,395,000 -22.71
2022 16,177,000 2,727,000 13,450,000 -14.58
2021 18,265,000 2,520,000 15,745,000 17.25
2020 15,865,000 2,437,000 13,428,000 29.23
2019 12,848,000 2,457,000 10,391,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS